Manning Anthony M. 4
4 · Monte Rosa Therapeutics, Inc. · Filed May 22, 2026
Research Summary
AI-generated summary of this filing
Monte Rosa (GLUE) Director Anthony Manning Exercises Options, Sells Shares
What Happened
Anthony M. Manning, a director of Monte Rosa Therapeutics (GLUE), exercised stock options and sold shares on 2026-05-21. He exercised 10,000 shares at $4.16 per share (cost = $41,600) and sold 10,000 shares in an open-market transaction at $18.01 per share (proceeds = $180,100). The filing also shows a separate derivative conversion/disposition of 10,000 shares reported at $0.00 consideration; the filing excerpt does not explain that $0.00 entry. Footnotes state the optioned shares were fully vested and exercisable.
Key Details
- Transaction dates: 2026-05-21 (filed on Form 4: 2026-05-22 — appears timely)
- Exercise (code M): 10,000 shares at $4.16 → $41,600 total cost
- Sale (code S): 10,000 shares at $18.01 → $180,100 total proceeds
- Derivative conversion/disposition: 10,000 shares at $0.00 (reported as disposed; filing does not explain)
- Shares owned after transaction: not specified in the provided filing excerpt
- Footnote: the option shares were fully vested and exercisable
Context
This sequence — exercising options and selling shares the same day — is commonly used to realize gains from vested options. The filing shows both an option exercise and an immediate open-market sale; one entry listed at $0.00 may reflect a non-cash settlement or withholding but is not described in the filing excerpt. No 10b5-1 plan, gift, or tax-withholding details are specified in the provided information.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-05-21$4.16/sh+10,000$41,600→ 10,000 total - Sale
Common Stock
2026-05-21$18.01/sh−10,000$180,100→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1]2026-05-21−10,000→ 12,100 totalExercise: $4.16Exp: 2034-06-12→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option are fully vested and exercisable.